Elsevier

Heart Rhythm

Volume 5, Issue 9, September 2008, Pages 1257-1264
Heart Rhythm

Original-clinical
Real-time three-dimensional echocardiography as a novel approach to assess left ventricular and left atrium reverse remodeling and to predict response to cardiac resynchronization therapy

https://doi.org/10.1016/j.hrthm.2008.05.021Get rights and content

Background

Real-time 3-dimensional echocardiography (RT3DE) is a novel promising technique for the assessment of left ventricular (LV) dyssynchrony.

Objective

This study sought to explore the value of RT3DE to assess LV and left atrium (LA) reverse remodeling and to predict response to cardiac resynchronization therapy (CRT).

Methods

A total of 57 consecutive heart failure patients scheduled for CRT were included, and RT3DE was performed before and 6 months after implantation. LV dyssynchrony was defined as the standard deviation of the time to reach the minimum systolic volume for 16 LV segments, expressed in percentage of cardiac cycle (systolic dyssynchrony index, SDI). Patients were divided into responders or nonresponders, based on a reduction ≥15% in LV end-systolic volume after CRT.

Results

Six patients (10%) were excluded from further analysis because of suboptimal images. Of the remaining 51 patients, 34 (67%) were classified as responders. Baseline characteristics were similar between responders and nonresponders, except for the SDI, which was larger in responders (9.7% ± 3.6% versus 5.1% ± 1.8%, P <.0001). ROC curve analysis revealed that a cutoff value for SDI of 6.4% yielded a sensitivity of 88% with a specificity of 85% to predict response to CRT. In responders, RT3DE also showed beneficial effects of CRT on LA: (1) significant LA reverse remodeling; (2) significant improvement in LA total emptying fraction and in LA conduit and reservoir function.

Conclusion

RT3DE allows assessment of changes in LV and LA volumes and function after CRT, and it is highly predictive for response to CRT.

Introduction

Cardiac resynchronization therapy (CRT) is considered an additional therapeutic option in heart failure patients who remain highly symptomatic despite optimized medical treatment.1 Large studies have shown a significant improvement in clinical and echocardiographic endpoints.2 However, up to 30% of the patients do not respond to CRT when selection is based on the traditional clinical and electrocardiographic criteria.3 In the search for better selection criteria for CRT, it has been shown that a direct echocardiographic assessment of left ventricular (LV) dyssynchrony is highly predictive for response to CRT.4 A novel echocardiographic technique has emerged for the assessment of LV dyssynchrony based on the analysis of regional volumetric changes: real-time 3-dimensional echocardiography (RT3DE). Promising results for the assessment of LV dyssynchrony have been shown when RT3DE was applied in patients with varying degrees of LV dysfunction and in normal subjects.5 Furthermore, we have recently shown the value of RT3DE to predict acute echocardiographic response to CRT.6 Clinically more important however, is the response at long-term follow-up. In the current study, the value of RT3DE both to assess LV reverse remodeling and to predict echocardiographic response to CRT was evaluated at 6-month follow-up.

In addition, it has been shown recently that RT3DE provides a highly accurate evaluation of left atrium (LA) size and function7, 8 that are established markers of adverse cardiovascular outcomes.9, 10, 11 Few data are available about the effect of CRT on LA remodeling and function.12 In the current study, it was hypothesized that a favorable response to CRT would also lead to an improvement in LA size and function.

Section snippets

Study population and protocol

The study population consisted of 57 consecutive patients with heart failure scheduled for CRT implantation. Traditional selection criteria for CRT were applied: New York Heart Association (NYHA) functional class III to IV, LV ejection fraction (EF) ≤35%, and QRS duration >120 ms. Patients with atrial fibrillation were excluded to allow a complete evaluation of LA function. Of note, acute results after CRT in 42 of these patients have been reported recently.6 Before CRT implantation and at

Pacemaker implantation

The LV pacing lead was inserted transvenously via the subclavian route and positioned as far as possible in a lateral or posterolateral vein. The right atrial and ventricular leads were positioned in the right atrial appendage (or on the right atrium lateral wall) and in the right ventricular apex, respectively. All patients received a combined device (CRT-D; Contak Renewal, Boston Scientific, St Paul, MN.; Insync III-CD or Insync Sentry, Medtronic Inc. Minneapolis, MN) without major

Statistical analysis

Continuous data are presented as mean ± standard deviation. Categorical data are presented as absolute numbers or percentages. The t test and chi-square test were used for appropriate comparisons. Changes in NYHA class, LV filling pattern, and mitral regurgitation before and after CRT have been evaluated with a Wilcoxon ranks test. To determine the relationship between baseline variables and echocardiographic response to CRT, logistic regression analysis was applied. First, univariate analysis

Study population

Six patients (10.5%) were excluded from further analysis because of suboptimal images; baseline characteristics of the remaining 51 patients are summarized in Table 1. RT3DE revealed severe LV dilatation (mean LV end-diastolic volume 200 ± 47 ml), with depressed LV function (mean LV EF 28% ± 6%). Furthermore, a moderate to severe LA dilatation (LAmax 40 ± 18 ml/m2) and dysfunction (LA EF 36% ± 14%) was observed.19, 20

Mean LV dyssynchrony (SDI) was 8.4% ± 3.9%, and the latest activated LV wall

Discussion

In the current study, RT3DE showed a significant improvement in LV remodeling and function at 6 months after CRT associated with a significant improvement in LA volumes and function. In addition, LV dyssynchrony (as measured with SDI) was the only predictor of echocardiographic response to CRT with high sensitivity and specificity.

Study limitations

The patient cohort was relatively small, and the predictive value of RT3DE needs to be assessed for clinical endpoints and confirmed in larger prospective studies. Data on scar tissue and the exact LV lead position were not systematically available, which have been shown to affect response to CRT.27, 28 Also, the contribution of reduction in mitral regurgitation on LA size and function after CRT should be explored in a larger group of patients.

Conclusion

RT3DE allows assessment of the effects of CRT on LV and LA volumes and function. Baseline LV dyssynchrony (as measured with SDI) is predictive for echocardiographic response to CRT.

References (28)

  • N. Freemantle et al.

    Cardiac resynchronisation for patients with heart failure due to left ventricular systolic dysfunction—a systematic review and meta-analysis

    Eur J Heart Fail

    (2006)
  • J.G. Cleland et al.

    The effect of cardiac resynchronization on morbidity and mortality in heart failure

    N Engl J Med

    (2005)
  • S. Kapetanakis et al.

    Real-time three-dimensional echocardiography: a novel technique to quantify global left ventricular mechanical dyssynchrony

    Circulation

    (2005)
  • N. Ajmone Marsan et al.

    Real-time three-dimensional echocardiography permits quantification of left ventricular mechanical dyssynchrony and predicts acute response to cardiac resynchronization therapy

    J Cardiovasc Electrophysiol

    (2007)
  • Cited by (68)

    • Usefulness of overlapping of the e and A waves of the transmitral flow as a predictor of responders to cardiac resynchronization therapy

      2013, American Journal of Cardiology
      Citation Excerpt :

      However, no single echocardiographic measurement of dyssynchrony appears to have had a clinically relevant impact in large clinical trials.2,3 Two-dimensional speckle-tracking imaging and real-time 3-dimensional echocardiography are promising methods to decrease nonresponse.12–17 However, the reproducibility of these echocardiographic parameters remains controversial.

    View all citing articles on Scopus

    Dr. Marsan is financially supported by the Research Fellowship of the European Society of Cardiology. Dr. Bax has received research grants from Medtronic, Boston Scientific, BMS medical imaging, St. Jude Medical, GE Healthcare. Dr. Schalij has received research grants from Biotronik, Medtronic, and Boston Scientific.

    View full text